1. Home
  2. EDD vs SMTI Comparison

EDD vs SMTI Comparison

Compare EDD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

EDD

Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

N/A

Current Price

$5.81

Market Cap

375.1M

Sector

Finance

ML Signal

N/A

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$34.19

Market Cap

313.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDD
SMTI
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.1M
313.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
EDD
SMTI
Price
$5.81
$34.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
443.3K
344.1K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
7.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.47
52 Week Low
$4.96
$16.05
52 Week High
$6.18
$35.70

Technical Indicators

Market Signals
Indicator
EDD
SMTI
Relative Strength Index (RSI) 46.21 81.05
Support Level $5.73 $20.47
Resistance Level $6.03 $34.33
Average True Range (ATR) 0.08 0.74
MACD -0.01 0.14
Stochastic Oscillator 16.60 97.65

Price Performance

Historical Comparison
EDD
SMTI

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: